PGD

Vintage Investment Partners Announces Two New Members of Its Strategic Advisory Board

Retrieved on: 
Tuesday, January 30, 2024
Entrepreneurship, Senior, Presidency of Barack Obama, GBS, National Council, Former, Hadassah Medical Center, Research, Ovarian cancer, Hebrew University of Jerusalem, Bank, Genius, CFA, Bank of Israel, University, LLB, Fidelity, Central Waqf Council, Economics, PGD, P&G, Education, Strauss Group, MIT, Berkshire Partners, Analysis Group, SAB, Bank Leumi, GMO, CDPQ, Finance, Harvard University, Doctor of Philosophy, First Nations in Manitoba, Cincinnati metropolitan area, Defense, IBM Consulting, Bed Bath & Beyond, Teaching, Management

Dr. Haj-Yehia served between 2019-2023 as Executive Group Chairman of Bank Leumi, the largest and oldest bank in Israel.

Key Points: 
  • Dr. Haj-Yehia served between 2019-2023 as Executive Group Chairman of Bank Leumi, the largest and oldest bank in Israel.
  • "I am thrilled to have Samer and Andy join our Strategic Advisory Board.
  • More importantly, both bring unique experience and perspectives to Vintage that we are thrilled to tap", said Alan Feld, Founder and Co-Managing Partner of Vintage.
  • The other members of the Vintage SAB include: Bradley Bloom, Former Chairman and Co-Founder of Berkshire Partners, Mark Dubowitz, CEO, Foundation for the Defense of Democracies, Ambassador S. Fitzgerald Haney, Former U.S.

Paragonix SherpaPak Recognized for Maximizing Access to the Donor Pool in New Clinical Study

Retrieved on: 
Tuesday, January 9, 2024
General Health, Health, Surgery, Organ transplantation, Medical University of Vienna, Patient, Risk, CTS, Medical school, Survival, Freezing, Lung transplantation, ECMO, PGD, Physician, Dentistry

The use of extended criteria donor organs can increase the availability of life-saving transplantable organs, proving to be a valuable solution to those on the waitlist in need of an organ transplant.

Key Points: 
  • The use of extended criteria donor organs can increase the availability of life-saving transplantable organs, proving to be a valuable solution to those on the waitlist in need of an organ transplant.
  • The Paragonix SherpaPak CTS is a static hypothermic preservation device intended to protect the donor heart during transit, standardizing the internal environment to maintain a recommended thermal range above freezing, unlike traditionally used ice-cold storage.
  • Published in the esteemed Journal of Heart and Lung Transplantation, this study compared the effectiveness of ice-cold storage against the Paragonix SherpaPak CTS, assessing the post-transplant outcomes of recipients who received an extended criteria donor heart.
  • “The study finds the Paragonix SherpaPak Cardiac Transport System provides a clinically effective solution to safely increase donor heart utilization.

SUNSEEKER RESORT CHARLOTTE HARBOR IS NOW OPEN

Retrieved on: 
Monday, December 18, 2023
PGD, Collection, Sunseeker, Aileron, News, Love, Allegiant, Allegiant Travel Company, Punta Gorda Airport, Travel, Senior, Hotel

PORT CHARLOTTE, Fla., Dec. 18, 2023 /PRNewswire/ -- The highly anticipated Sunseeker Resort Charlotte Harbor is now open as they welcomed their first guests on December 15, 2023. The independently flagged property features 785 well-appointed guest rooms including 189 top-tier luxury Sunsuites™ and is the first completely new-build resort with more than 750 rooms to open in Southwest Florida in over thirteen years.

Key Points: 
  • PORT CHARLOTTE, Fla., Dec. 18, 2023 /PRNewswire/ -- The highly anticipated Sunseeker Resort Charlotte Harbor is now open as they welcomed their first guests on December 15, 2023.
  • To commemorate the opening, Sunseeker Resort Charlotte Harbor hosted a ribbon-cutting ceremony along with local officials including Charlotte County Commissioner Bill Truex and the Sunseeker Resort executive team including President Micah Richins, Senior Vice President Jason Shkorupa, and their entire executive committee as they welcomed the first guests.
  • "Simply put, there is not a single collection of hotel amenities that rival Sunseeker Resort Charlotte Harbor along the Gulf Coast.
  • Sunseeker Resort Charlotte Harbor is located at 5500 Sunseeker Way, Charlotte Harbor, FL 33980.

94.1 percent of Kuwaiti Women Consider Thalassemia Screening after Learning about Health Risks

Retrieved on: 
Friday, November 17, 2023
Woman, GM, Behavior, Policy, Prevalence, Genetic counseling, Hospital, Learning, Patient, Genomics, BGI Group, PGD, BGI, Female, Knowledge, Online shopping, Medical device, Thalassemia

RIYADH, Saudi Arabia, Nov. 17, 2023 /PRNewswire/ -- To facilitate greater understanding of thalassemia, a hereditary hemoglobinopathy, BGI Genomics today released its State of Thalassemia Awareness Report. This report assesses the level of knowledge and attitudes related to the associated health risks, thalassemia carrier screening, and genetic counseling for carriers. 1,847 female respondents from six countries with high thalassemia prevalence were surveyed: Azerbaijan, China, Indonesia, Kuwait, Saudi Arabia, and Thailand.

Key Points: 
  • This report assesses the level of knowledge and attitudes related to the associated health risks, thalassemia carrier screening, and genetic counseling for carriers.
  • 1,847 female respondents from six countries with high thalassemia prevalence were surveyed: Azerbaijan, China, Indonesia, Kuwait, Saudi Arabia, and Thailand.
  • 94.1% of Kuwaiti women consider screening after learning about associated thalassemia health risks and costs which is higher than the global average of 84.5%.
  • Thalassemia carriers are more open to genetic counseling: If both partners are thalassemia carriers, 50.8% of women can persuade their partners to seek genetic counseling and consider PGD.

SUNSEEKER RESORT CHARLOTTE HARBOR TO OFFICIALLY WELCOME ITS FIRST GUESTS DECEMBER 15, 2023

Retrieved on: 
Thursday, November 2, 2023
The Newest Pledge, PORT, News, PGD, Aileron, Punta Gorda Airport, Hotel, Gulf Coast of the United States

PORT CHARLOTTE, Fla., Nov. 2, 2023 /PRNewswire/ -- The highly anticipated Sunseeker Resort Charlotte Harbor announces an official opening date of December 15, 2023. The independently flagged property features 785 well-appointed guest rooms including 189 top-tier luxury Sunsuites™, and will be the first completely new-build resort with more than 750 rooms to open in Southwest Florida in over thirteen years.

Key Points: 
  • The highly anticipated Sunseeker Resort Charlotte Harbor announces an official opening date of December 15, 2023.
  • In addition to its prime waterfront location, Sunseeker Resort Charlotte Harbor will feature a world class 18-hole golf course, Aileron Golf Club, exclusive to hotel guests.
  • Guests staying at Sunseeker Resort Charlotte Harbor will be able to pick from a signature list of guestrooms and suites.
  • Sunseeker Resort Charlotte Harbor is located at 5500 Sunseeker Way, Charlotte Harbor, FL 33980.

Expansive Clinical Study Finds Improved Outcomes in Heart Transplant Patients Utilizing Paragonix Advanced Organ Preservation

Retrieved on: 
Thursday, September 7, 2023
Surgery, FDA, Clinical Trials, Cardiology, Other Health, Biotechnology, General Health, Pharmaceutical, Health, Oncology, PGD, ASAIO, Data collection, Research, American Society for Artificial Internal Organs, Trial of the century, Ice, Patient, Investment, Stanford University School of Medicine, MCS, Society, Dentistry

Paragonix Technologies, Inc ., a leading organ transplant company, announced today the publication of groundbreaking research from a clinical study on patient outcomes following heart transplant surgery.

Key Points: 
  • Paragonix Technologies, Inc ., a leading organ transplant company, announced today the publication of groundbreaking research from a clinical study on patient outcomes following heart transplant surgery.
  • Published in The American Society for Artificial Internal Organs (ASAIO), the study utilized data collected by the GUARDIAN-Heart Registry, the world’s largest clinical database dedicated to donor heart preservation, to analyze post-transplant outcomes and the impact on organ preservation methods on transplant patient health.
  • The US multi-center analysis of GUARDIAN Registry data included 569 adult patients who received heart transplants between October 2015 and January 2022 .
  • “Particularly, in the post-allocation change era, with increasing travel distances and ischemic times, advanced hypothermic organ preservation is an important resource for transplant centers to consider.”
    “The ongoing results of the GUARDIAN-Heart Registry have shown advanced preservation to be a potential game-changer for heart transplant patients.

ALLEGIANT ANNOUNCES SIX NEW ROUTES WITH ONE-WAY FARES AS LOW AS $40*

Retrieved on: 
Tuesday, July 11, 2023
AZA, Heart, PGD, Phoenix–Mesa Gateway Airport, Travel, Orlando Sanford International Airport, FLL, MOT, Melbourne Orlando International Airport, Friends, Nashville International Airport, Tax, Portland International Airport, SFB, BNA, Punta Gorda Airport, Allegiant, Fort Lauderdale–Hollywood International Airport, BGR, Government, PDX, Lehigh Valley International Airport, Eastern Iowa Airport, International airport, MLB, Fortification, Minot International Airport, ABE, CID, Family, Bangor International Airport, Tourism, Airline

LAS VEGAS, July 11, 2023 /PRNewswire/ -- Allegiant (NASDAQ: ALGT) today announced six new nonstop routes to popular vacation destinations that will start just in time for the winter holidays. To celebrate, the company is offering one-way fares on the new routes as low as $40.*

Key Points: 
  • To celebrate, the company is offering one-way fares on the new routes as low as $40.
  • *
    The routes, launching this November, will connect communities across the country to popular vacation spots including Nashville, Portland, Phoenix/Mesa, and several Florida destinations.
  • The new routes to Fort Lauderdale-Hollywood International Airport (FLL) in Florida include:
    Nashville, Tennessee via Nashville International Airport (BNA) – beginning Nov. 16, 2023 with one-way fares as low as $40.
  • *
    Cedar Rapids, Iowa via Eastern Iowa Airport (CID) – beginning Nov. 17, 2023 with one-way fares as low as $60.

Clinical Study of Over 1,000 Transplant Recipients Demonstrates Improved Clinical Outcomes in Heart Transplantation with the Paragonix SherpaPak

Retrieved on: 
Friday, April 21, 2023
Cardiology, Biotechnology, Other Health, Health, General Health, Health Technology, Research, Hospitals, Surgery, Science, Clinical Trials, PGD, Mortality, University, Patient, Risk, Dentistry

GUARDIAN clinical investigators and 21 independent transplant centers presented extensive findings in over 20 presentations throughout the conference, detailing the impact of advanced donor heart preservation and the clinical benefits that transplant recipients experienced with the use of the Paragonix SherpaPak Cardiac Transport System.

Key Points: 
  • GUARDIAN clinical investigators and 21 independent transplant centers presented extensive findings in over 20 presentations throughout the conference, detailing the impact of advanced donor heart preservation and the clinical benefits that transplant recipients experienced with the use of the Paragonix SherpaPak Cardiac Transport System.
  • The conclusions of multiple research presentations highlighted that the use of a Paragonix SherpaPak system is associated with a reduction in common post-transplant complications, as well as an increase in survival rates.
  • Notably, the most impactful results consistently demonstrate a significant reduction in Severe Primary Graft Dysfunction (PGD), a serious post-transplant complication.
  • At Paragonix, our relentless efforts to advance clinical research in donor organ preservation are driven by our commitment to improving the lives of both current and future organ transplant patients.”

Paragonix LUNGguard™ System Shown to Reduce Hospital Readmission Rates in Lung Transplant Recipients

Retrieved on: 
Thursday, April 20, 2023
Research, Surgery, Hospitals, Clinical Trials, Health Technology, Other Health, Biotechnology, General Health, Health, Science, PGD, Duke University, Length of stay, Temperature, Ice, Patient, FDA, Dentistry

The study compares conventional ice-cold storage to the Paragonix LUNGguard™ system, using real-world multi-center data collected from the GUARDIAN-Lung Registry.

Key Points: 
  • The study compares conventional ice-cold storage to the Paragonix LUNGguard™ system, using real-world multi-center data collected from the GUARDIAN-Lung Registry.
  • The analysis illustrates that advanced lung preservation technology favorably influences post-transplant outcomes, including a 24% reduction in 1-year readmission rates (p=0.018).
  • 1 One-year readmission rates can be an indication of potential costly post-transplant complications, making the results of the study an important development for lung transplant centers.
  • Lung Transplant Centers, as well as multiple centers across Europe, trust LUNGguard to safeguard donor organs en route to their waitlist patients.

Clinical Evidence Points to Paragonix SherpaPak as Potential Solution to Expand Donor Heart Pool

Retrieved on: 
Thursday, April 20, 2023
Technology, Research, Other Technology, Clinical Trials, Cardiology, Biotechnology, Health, General Health, Science, PGD, Surgeon, Survival, ECMO, Medical school, Transplant, Patient, Risk, Organ transplantation, Medical University of Vienna, FDA, Medical device, Dentistry

Paragonix Technologies, Inc. , the leader in organ preservation technology and research, has presented new groundbreaking data on the clinical impact of using Paragonix SherpaPak Cardiac Transport System to preserve donor hearts from extended criteria donors.

Key Points: 
  • Paragonix Technologies, Inc. , the leader in organ preservation technology and research, has presented new groundbreaking data on the clinical impact of using Paragonix SherpaPak Cardiac Transport System to preserve donor hearts from extended criteria donors.
  • This recent study compared the use of traditional ice-cold storage to the Paragonix SherpaPak® Cardiac Transport System, the leading FDA-cleared and CE-marked medical device for donor heart preservation, to measure the post-transplant outcomes of recipients who received an extended criteria donor heart.
  • Key findings of this study include:
    - 13.9% of patients who received a donor heart preserved on conventional ice storage reported Severe PGD, compared to 6.2% utilizing the Paragonix SherpaPak System (p=0.022).
  • “It is encouraging to share real-world data that shows how we can potentially expand the donor pool by utilizing this technology, and ultimately increase the number of life-saving heart transplants.”